Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 10
Submit an article Journal homepage
150
Views
10
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer

Michael A Ströhlein Department of Abdominal, Vascular and Transplant Surgery, Cologne Merheim Medical Center, Witten/Herdecke University, Ostmerheimer Str. 200, D-51109 Cologne, Germany;[email protected]
,
Dirk R Bulian Department of Abdominal, Vascular and Transplant Surgery, Cologne Merheim Medical Center, Witten/Herdecke University, Ostmerheimer Str. 200, D-51109 Cologne, Germany; Department of Abdominal, Vascular and Transplant Surgery, Cologne Merheim Medical Center, Witten/Herdecke University, Ostmerheimer Str. 200, D-51109 Cologne, Germany
&
Markus M Heiss Department of Abdominal, Vascular and Transplant Surgery, Cologne Merheim Medical Center, Witten/Herdecke University, Ostmerheimer Str. 200, D-51109 Cologne, Germany; Department of Abdominal, Vascular and Transplant Surgery, Cologne Merheim Medical Center, Witten/Herdecke University, Ostmerheimer Str. 200, D-51109 Cologne, Germany
Pages 1505-1508 | Published online: 10 Jan 2014

References

  • Yang XJ, Huang CQ, Suo T et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a Phase III randomized clinical trial. Ann. Surg. Oncol.18(6), 1575–1581 (2011).
  • Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin. Surg. Oncol.21(4), 233–248 (2003).
  • Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology58(2), 96–107 (2000).
  • Yonemura Y, Elnemr A, Endou Y et al. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J. Gastrointest. Oncol.2(2), 85–97 (2010).
  • Sadeghi B, Arvieux C, Glehen O et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer88(2), 358–363 (2000).
  • Boku N. Chemotherapy for metastatic disease: review from JCOG trials. Int. J. Clin. Oncol.13(3), 196–200 (2008).
  • Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol.7(1), 69–76 (2006).
  • Elias D, Lefevre JH, Chevalier J et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J. Clin. Oncol.27(5), 681–685 (2009).
  • Elias D, Pocard M, Goere D. HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat. Res.134, 303–318 (2007).
  • Glehen O, Gilly FN, Arvieux C et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann. Surg. Oncol.17(9), 2370–2377 (2010).
  • Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Brit. J. Surg.92(3), 370–375 (2005).
  • Hall JJ, Loggie BW, Shen P et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J. Gastrointest. Surg.8(4), 454–463 (2004).
  • Yonemura Y, Endou Y, Sasaki T et al. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur. J. Surg. Oncol.36(12), 1131–1138 (2010).
  • Glehen O, Gilly FN, Cotte E. Hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: the end of skepticism? Ann. Surg. Oncol.18(6), 1524–1526 (2011).
  • Ströhlein MA, Lordick F, Rüttinger D et al. Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, Phase I/II trial. Onkologie34(3), 101–110 (2011).
  • Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J. Surg. Oncol.7, 5 (2009).
  • Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Eng. J. Med.355(1), 11–20 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.